Inactive Instrument

News Santarus, Inc.

Equities

US8028173040

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2013	The Ryland Group, Inc. : Dow, S&P 500 end higher for fifth straight week; financials lead	RE
2013	Santarus, Inc. : Salix bolsters gastro drug line-up with $2.6 billion Santarus buy	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Santarus, Inc. : Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera	13-12-31	PR
Santarus, Inc. : Santarus Announces Availability of Amended Tender Offer Materials	13-12-30	BU
Santarus, Inc. : Santarus Initiates Phase IIa Study with SAN-300 in Patients with Active Rheumatoid Arthritis	13-12-23	BU
Santarus, Inc. : Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc.	13-11-11	PR
The Ryland Group, Inc. : Dow, S&P 500 end higher for fifth straight week; financials lead	13-11-08	RE
Santarus, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Santarus, Inc. Stockholders	13-11-08	BU
Santarus, Inc. : Law Offices of Howard G. Smith Announces Investigation of Santarus Inc.	13-11-08	BU
Santarus, Inc. : Investor Alert: Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of Santarus, Inc.	13-11-08	BU
Santarus, Inc. : Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Santarus, Inc. Proposed Acquisition by Salix Pharmaceuticals, Ltd.	13-11-08	BU
Santarus, Inc. : Law Firm Brower Piven Announces Investigation of Santarus, Inc. Proposed Buyout	13-11-08	BU
Santarus, Inc. : Santarus and Pharming Announce New Data from Open-Label Repeat Treatment Study with RUCONEST (Recombinant Human C1 Esterase Inhibitor)	13-11-08	PU
Santarus, Inc. : Salix bolsters gastro drug line-up with $2.6 billion Santarus buy	13-11-07	RE
Santarus, Inc. : Santarus Reports Third Quarter 2013 Financial Results	13-11-07	BU
Santarus, Inc. : Salix Pharmaceuticals to Acquire Santarus	13-11-07	BU
Santarus, Inc. : Acquisitions, Financial Results, Clinical Trial Applications, and Upcoming Earnings Schedules - Research Report on Illumina, DENTSPLY, Alnylam, Sirona, and Santarus	13-11-01	PR
Santarus, Inc. : Santarus to Hold Third Quarter 2013 Financial Results Conference Call on November 7	13-10-28	BU
Santarus, Inc. : Santarus Announces Presentation of SAN-300 Phase I Data at 2013 American College of Rheumatology Annual Meeting	13-10-25	BU
Santarus, Inc. : Santarus Announces Presentation of Phase III Data for Rifamycin SV MMX in Travelers' Diarrhea	13-10-04	BU
Santarus, Inc. : Pre-Market Review: Isis Pharmaceuticals Inc., Community Health Systems Inc., Quest Diagnostics Inc., and Santarus Inc.	13-09-12	PR
Santarus, Inc. : Santarus to Present at September Investment Conferences	13-09-03	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Santarus, Inc.

Equities

US8028173040

Summary

Filters